Status and Development Trend of Evaluation of Post-Marketing Traditional Chinese Medicines in China  

作　　者：WEI Rui-li WANG Zhi-fei XIE Yan-ming 魏瑞丽;王志飞;谢雁鸣(Institute of Basic Research on Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China)

机构地区：[1]Institute of Basic Research on Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China

出　　处：《World Journal of Integrated Traditional and Western Medicine》2020年第6期15-22,共8页世界中西医结合杂志（英文）

摘　　要：Evaluation of traditional Chinese medicines after the market has achieved fruitful results after years of development.The real-world research concept has been first proposed by Chief Researcher Xie Yanming in 2010 and to 2020 with the approval of the National Medical Products Administration to use real-world evidence to support drug development and review in 2020.Real-world data application and transformation continue to cause heated discussions in the industry.Real-world research concepts have been added new motivation into the evaluation of Chinese medicines after they are marketed.The development of the Chinese patent medicine industry is facing unprecedented opportunities and challenges.

关 键 词：Evaluation of traditional Chinese medicines after marketing Real world research Clinical safety evaluation PHARMACOVIGILANCE 

分 类 号：R288[医药卫生—中药学]